Cargando…

The Role of Chemokine Receptor CXCR3 and Its Ligands in Renal Cell Carcinoma

The major invasive subtype of kidney cancer is renal cell carcinoma (RCC). The essential components of cancer development are chronic inflammation and neoangiogenesis. It has been suggested that the chemokine ligand 9, -10, –11 (CXCL9–11) and chemokine receptor 3 (CXCR3) chemokines receptor expresse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gudowska-Sawczuk, Monika, Kudelski, Jacek, Mroczko, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696621/ https://www.ncbi.nlm.nih.gov/pubmed/33202536 http://dx.doi.org/10.3390/ijms21228582

Ejemplares similares

Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2020)

Higher Content but Not Activity of Stromelysin-2 (MMP-10) in Comparison to Stromelysin-1 (MMP-3) in Human Renal Carcinoma
por: Kudelski, Jacek, et al.
Publicado: (2022)

Enhanced Expression but Decreased Specific Activity of Matrix Metalloproteinase 10 (MMP-10) in Comparison with Matrix Metalloproteinase 3 (MMP-3) in Human Urinary Bladder Carcinoma
por: Kudelski, Jacek, et al.
Publicado: (2021)

The Clinical Significance of Serum Free Light Chains in Bladder Cancer
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2023)

The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2021)

What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection?
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2022)

The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2022)

The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
por: Kudelski, Jacek, et al.
Publicado: (2023)

Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2019)

Selected Biomarkers of Tick-Borne Encephalitis: A Review
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2021)

Free Light Chains κ and λ as New Biomarkers of Selected Diseases
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2023)

Higher Content but No Specific Activity in Gelatinase B (MMP-9) Compared with Gelatinase A (MMP-2) in Human Renal Carcinoma
por: Młynarczyk, Grzegorz, et al.
Publicado: (2023)

Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
por: Litman-Zawadzka, Ala, et al.
Publicado: (2020)

The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer
por: Kuo, Paula T., et al.
Publicado: (2018)

The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2016)

Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases
por: Altara, R, et al.
Publicado: (2016)

Immunohistochemical Expression of Chemokine Receptor CXCR3 and its Ligand CXCL 11 in Basal Cell Carcinoma
por: Ansari, Mariya K., et al.
Publicado: (2023)

Kappa Free Light Chains and IgG Combined in a Novel Algorithm for the Detection of Multiple Sclerosis
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2020)

COVID-19: The Course, Vaccination and Immune Response in People with Multiple Sclerosis: Systematic Review
por: Bazylewicz, Marcin, et al.
Publicado: (2023)

Free Immunoglobulin Light Chains in Patients with Tick-Borne Encephalitis: Before and after Treatment
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2021)

Emerging Importance of Chemokine Receptor CXCR4 and Its Ligand in Liver Disease
por: Wang, Sheng, et al.
Publicado: (2021)

Evaluation of Free Light Chains (FLCs) Synthesis in Response to Exposure to SARS-CoV-2
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2022)

Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor
por: Dekkers, Sebastian, et al.
Publicado: (2023)

The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma
por: Stofas, Anastasios, et al.
Publicado: (2014)

The Role of Selected Chemokines and Their Receptors in the Development of Gliomas
por: Groblewska, Magdalena, et al.
Publicado: (2020)

Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma
por: Chifu, Irina, et al.
Publicado: (2020)

Computer‐aided assessment of the chemokine receptors CXCR3, CXCR4 and CXCR7 expression in gallbladder carcinoma
por: Yu, Xiao, et al.
Publicado: (2020)

The role of CXCR3 and its ligands in cancer
por: Wang, Xiaoming, et al.
Publicado: (2022)

Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands
por: Moussouras, Natasha A., et al.
Publicado: (2017)

The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease
por: Döring, Yvonne, et al.
Publicado: (2014)

Chemokine receptor CXCR4 oligomerization is disrupted selectively by the antagonist ligand IT1t
por: Ward, Richard J., et al.
Publicado: (2020)

The chemokine receptor CXCR4 and its ligand CXCL12 are activated during implantation and placentation in sheep
por: Ashley, Ryan L, et al.
Publicado: (2011)

Chemokines in Primary Liver Cancer
por: Zajkowska, Monika, et al.
Publicado: (2022)

Strong Expression of Chemokine Receptor CXCR4 by Renal Cell Carcinoma Correlates with Advanced Disease
por: Wehler, Thomas C., et al.
Publicado: (2008)

Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives
por: Pawig, Lukas, et al.
Publicado: (2015)

Agonists for the Chemokine Receptor CXCR4
por: Lefrançois, Marilou, et al.
Publicado: (2011)

Expression of the chemokine receptor CXCR4 in human hepatocellular carcinoma and its role in portal vein tumor thrombus
por: Li, Nan, et al.
Publicado: (2010)

Atypical Roles of the Chemokine Receptor ACKR3/CXCR7 in Platelet Pathophysiology
por: Chatterjee, Madhumita
Publicado: (2022)

The ELR(+)CXCL chemokines and their receptors CXCR1/CXCR2: A signaling axis and new target for the treatment of renal cell carcinoma
por: Giuliano, Sandy, et al.
Publicado: (2014)

Serum CXCL8 and Its Specific Receptor (CXCR2) in Gastric Cancer
por: Pawluczuk, Elżbieta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5ku79aeado8q99jhnv71cp36ql